RJA
GOCO

Raymond James & Associates’s GoHealth GOCO Stock Holding History

Raymond James & Associates’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,883
Closed -$51K – 4097
2022
Q1 		$51K Sell
2,883
-17,655
-86% -$549K ﹤0.01% 3907
2021
Q4 		$1.17M Sell
20,538
-3,453
-14% -$230K ﹤0.01% 2522
2021
Q3 		$1.81M Sell
23,991
-78,436
-77% -$8.3M ﹤0.01% 2174
2021
Q2 		$17.2M Buy
102,427
+81,170
+382% +$14.2M 0.02% 790
2021
Q1 		$3.73M Buy
+21,257
New +$4.29M ﹤0.01% 1615

Other funds holding GOCO

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Raymond James & Associates's GOCO Position: Q2 2022 in Review

Raymond James & Associates sold out of GoHealth (GOCO) in Q2 2022, closing a stake of 2,883 shares — an estimated $51K sold.

Raymond James & Associates first reported a position in GOCO in Q1 2021 and held it in 5 quarters. The position peaked at $17.2M in Q2 2021. 77 funds tracked by Wall St. Rank hold GOCO as of Q2 2022.

  • Raymond James & Associates reported no remaining GoHealth position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 2,883 GoHealth shares in Q2 2022, an estimated $51K.
  • Raymond James & Associates first reported a position in GoHealth in Q1 2021 and held it in 5 quarters.
  • Raymond James & Associates's GoHealth position peaked at $17.2M in Q2 2021.
  • 77 funds tracked by Wall St. Rank held GoHealth as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.